←Back to Expert Scholars
Translational Medicine / 转化医学Sarcoma Drug Development
Jaap Verweij
MD, PhD
🏢Erasmus MC Cancer Institute🌐Netherlands
Professor Emeritus of Medical Oncology
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jaap Verweij led EORTC soft tissue and bone sarcoma group trials for many years and contributed to landmark studies of imatinib in GIST and sunitinib in advanced disease. His work at Erasmus MC shaped European sarcoma drug development. He is a recognized global sarcoma trialist.
Share:
🧪Research Fields 研究领域
sarcoma
GIST
imatinib
EORTC
drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jaap Verweij 的研究动态
Follow Jaap Verweij's research updates
留下邮箱，当我们发布与 Jaap Verweij（Erasmus MC Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment